312P Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC)

Journal article

Peer reviewed

R Mahtani, A Niyazov, K Lewis, L Massey, A Rider, B Arondekar and M.P Lux

Annals of oncology, Vol.31, pp.S367-S368

2020-09

Metrics

9 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 312P Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC)
Creators: R Mahtani - Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, USA
A Niyazov - Pfizer Inc., US Oncology, New York, NY, USA
K Lewis - Adelphi Real World, Oncology, Cheshire, UK
L Massey - Adelphi Real World, Oncology, Cheshire, UK
A Rider - Adelphi Real World, Oncology, Cheshire, UK
B Arondekar - Pfizer Inc., Global & US Immuno/Oncology, Collegeville, PA, USA
M.P Lux - Kooperatives Brustzentrum Paderborn, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Frauen- und Kinderklinik St. Louise, Paderborn, Germany
Publication Details: Annals of oncology, Vol.31, pp.S367-S368
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031598849102976